/ /

Christine Blank, Contributing Editor
Supreme Court Ruling Raises Biosimilars’ Access
High court ruling should make biosimilars available faster.
AAM Report on Generics Finds High Brand Abandonment Rate
Patients are less like to buy a requested brand name prescription than a generic one.
Pharmacist Intervention Improves Diabetes Drug Trials
Interventions by pharmacists can help improve the results of diabetes clinical trials.
How Diabetic Kids and Teens Can Improve Quality of Life
Good glucose control can help children and teens with type 1 diabetes boost their quality of life.
How to Cope with Residency Stress
Residency programs are teaching young pharmacists how to cope with stress.
Nevada Law on Diabetes Meds Has a Setback
The Nevada law to fight high diabetes drug prices has stumbled.
New Programs Aim to Curb Diabetes Drug Costs
Drug makers are starting plans to help patients pay for diabetes drugs.
Keep prescription drug benefits in ACA, NCPA urges
NCPA sends letter to Senate on prescription issues in health-care reform.
Costly new ALS treatment approved
FDA recently approved the first new treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, in more than 20 years.
Campaign gears up to combat high drug prices
Walmart, CVS Health, and a number of other healthcare organizations are supporting a new multi-million dollar consumer campaign to combat high prescription drug prices.

Poll

View Results